DATABASE

ABCDEFGHIJKLMNOPQRSTUVWXYZ


Name Category
Agennix AG Schedules Conference Call on November 30, 2012 to Discuss Third Quarter 2012 Financial Results News
Agennix Lung Cancer Drug in Doubt After Clinical Trial Failure News
Agennix Plunges as Cancer Drug Fails in Trial: Frankfurt Mover News
Agennix Reports Results of FORTIS-M Phase III Trial With Talactoferrin Alfa in Non-Small Cell Lung Cancer News
Agenus Announces Initiation of Enrollment in NCI-Sponsored Randomized Trial of Prophage G-200 Vaccine With Avastin in Treatment of Brain Tumors News
Agenus begins enrollment in NCI-Sponsored randomized trial of Prophage G-200 News
Agenus Eliminates its $39 Million Senior Notes and Completes $10 Million of New Debt Financing News
Agenus Eliminates Its $39 Million Senior Notes and Completes $10 Million of New Debt Financing News
AGENUS INC Files SEC form 10-Q, Quarterly Report News
AGENUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits News
AGENUS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits News
AGENUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits News
AGENUS INC Financials News
Agenus Inc. Fund
Agenus Reports First Quarter 2013 Financial Results News
Agenus to Report First Quarter 2013 Financial Results on April 24, 2013; Conference Call to Follow News
Agenus' CEO Discusses Q1 2013 Results - Earnings Call Transcript News
Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion News
AGF Actions SICAV ACT. /3 DECIMALES Fund
AGF American Growth Class Fund Front End Load Units (CAD) Fund
AGF American Growth Class Fund Front End Load Units (CAD) Fund
Agf Asset Management Bank
Agf Asset Management Bank
AGF Canadian Balanced Fund Trust Units - CAD Front End Load Fund
AGF Canadian Balanced Fund Trust Units /CAD Deferred Sales Charge Fund
Page 215 of 1100